Willingness of parents to vaccinate their 6–60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province

References

• Gu W, Zeng G, Hu YM, Hu YS, Zhang Y, Hu YL, Wang Y, Li JX, Zhu FC. A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3–5 years and infants aged 6–35 months. Expert Rev Vaccines. 2018;17(3):257–262. PMID: 29363365. doi:10.1080/14760584.2018.1430572.
   PubMed Web of Science ®Google Scholar
• Chen Z, Ren X, Yang J, Dong J, Xue Y, Sun L, Zhu Y, Jin Q. An elaborate landscape of the human antibody repertoire against enterovirus 71 infection is revealed by phage display screening and deep sequencing. MAbs. 2017;9(2):342–349. PMID: 27929745. doi:10.1080/19420862.2016.1267086.
   PubMed Web of Science ®Google Scholar
• Zhuang ZC, Kou ZQ, Bai YJ, Cong X, Wang LH, Li C, Zhao L, Yu XJ, Wang ZY, Wen HL. Epidemiological research on hand, foot, and mouth disease in Mainland China. Viruses. 2015;7(12):6400–11. PMID: 26690202. doi:10.3390/v7122947.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2010;7(1):1–9. PMID: 20459851. doi:10.1186/1743-422X-7-94.
   PubMedGoogle Scholar
• Mitsuaki H, Yukihiko K, Masatoki S, Honzumi K, Hayashi A, Hiroshima T, Ishiko H, Kato K, Suzuki H. Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003. J Clin Microbiol. 2007;45(1):112–120. PMID:17093028. doi:10.1128/JCM.00718-06.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim JH, Kang JH, Kim DS, Kim KH, Kim KH, Kim YH, Chung JY, Bin JH, Jung DE, et al. Risk factors for neurologic complications of hand, foot and mouth disease in the Republic of Korea, 2009. J Korean Med Sci. 2013;28(1):120–127. PMID:23341722. doi:10.3346/jkms.2013.28.1.120.
   PubMed Web of Science ®Google Scholar
• Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, Clear D, del Sel S, Chieng CH, Tio PH, Cardosa MJ, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. 2009;9(1):3–14. PMID:19152683. doi:10.1186/1471-2334-9-3.
   PubMedGoogle Scholar
• Phan Van T, Thao NTT, David P, Truong KH, Tien NTK, Thuong TC, How OM, Cardosa MJ, McMinn PC. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13(11):1733–41. PMID:18217559. doi:10.3201/eid1311.070632.
   PubMed Web of Science ®Google Scholar
• Wei AL, Kw K B, Kwai Peng C, Tee CL, Lyn J, Kee Tai G. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001–2007. Ann Acad Med Singapore. 2009;38(2):106–112. PMID:19271036.
   PubMed Web of Science ®Google Scholar
• Koh WM, Bogich T, Siegel K, Jin J, Chong EY, Tan CY, Chen MI, Horby P, Cook AR. The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis. Pediatr Infect Dis J. 2016;35(10):e285–e300. PMID: 27273688. doi:10.1097/INF.0000000000001242.
   PubMed Web of Science ®Google Scholar
• Weijia X, Qiaohong L, Cécile V, Jing Z, Junling S, Joseph TW, Zhaorui C, Fengfeng L, Vicky JF, Yingdong Z, et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. Lancet Infect Dis. 2014;14(4):308–318. PMID:24485991. doi:10.1016/S1473-3099(13)70342-6.
   PubMed Web of Science ®Google Scholar
• Zhijie A, Yan L, Qiaohong L, Yong Z, Yan L, Keli L, Chenyan Y, Yamin W, Qiyou X, Hongjie Y, et al. Technical guidelines for use of enterovirus 71 inactivated vaccine. Chin J Vaccines Immunization. 2016;22(4):458–64.
   Google Scholar
• Wang J, Teng Z, Cui X, Li C, Pan H, Zheng Y, Mao S, Yang Y, Wu L, Guo X, et al. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012–2016. Emerging Microbes Infect. 2018;7(1):8–19. PMID: 29362406. doi:10.1038/s41426-017-0011-z.
   PubMedGoogle Scholar
• Fengcai Z, Fanyue M, Jingxin L, Xiuling L, Qunying M, Hong T, Yuntao Z, Xin Y, Kai C, Qinghua C, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381(9882):2024–32. PMID: 23726161. doi:10.1016/S0140-6736(13)61049-1.
   PubMed Web of Science ®Google Scholar
• Fengcai Z, Wenbo X, Jielai X, Zhenglun L, Yan L, Xuefeng Z, Xiaojuan T, Ling W, Qunying M, Junyu W, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818–28. PMID:24571754. doi:10.1056/NEJMoa1304923.
   PubMed Web of Science ®Google Scholar
• Rongcheng L, Longding L, Zhaojun M, Xuanyi W, Jielai X, Zhenglun L, Ying Z, Yanping L, Qunying M, Jingjing W, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829–37. PMID: 24571755. doi:10.1056/NEJMoa1303224.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zeng G, Chu K, Zhang J, Han W, Zhang Y, Li J, Zhu F. Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: a further observation. Hum Vaccin Immunother. 2018;14(6):1517–23. PMID: 29482422. doi:10.1080/21645515.2018.1442997.
   PubMed Web of Science ®Google Scholar
• Wang W, Song J, Wang J, Li Y, Deng H, Li M, Gao N, Zhai S, Dang S, Zhang X, et al. Cost-effectiveness of a national enterovirus 71 vaccination program in China. PLoS Negl Trop Dis. 2017;11(9):e0005899. PMID: 28892475. doi:10.1371/journal.pntd.0005899.
   PubMed Web of Science ®Google Scholar
• Guangwu W, Lijuan B. Epidemiological and etiological analysis of HFMD in border area of Chongzuo city from 2008 to 2017. Chin J Dis Control Prev. 2018;22(10):1028–31. doi:10.16462/j.cnki.zhjbkz.2018.10.012.
   Google Scholar
• Xiaopu Z, Jun Z. Investigation on vaccination rate of EV71 vaccine in severe hand, foot and mouth in Qujing City and analysis of population inoculation intention. Health Way. 2017;14(8):248–49.
   Google Scholar
• Alberts CJ, Loeff MFSVD, Hazeveld Y, de Melker HE, van der Wal MF, Nielen A, El Fakiri F, Prins M, Paulussen TG. A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands. BMC Public Health. 2017;17(1):220–31. PMID: 28222722. doi:10.1186/s12889-017-4091-4.
   PubMedGoogle Scholar
• Gargano LM, Underwood NL, Sales JM, Seib K, Morfaw C, Murray D, DiClemente RJ, Hughes JM. Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt. Hum Vaccin. 2015;11(7):1641–47. PMID: 25996686. doi:10.1080/21645515.2015.1038445.
   PubMed Web of Science ®Google Scholar
• Tiegang L, Hui W, Yin L, Qin L, Chu C, Dahu W, Meixia L, Yilan L, Jianyuan L, Zongqiu C, et al. Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China. Vaccine. 2018;36(26):3772–78. PMID: 29776754. doi:10.1016/j.vaccine.2018.05.054.
   PubMed Web of Science ®Google Scholar
• Ji H, Fan H, Lu PX, Zhang XF, Ai J, Shi C, Huo X, Bao CJ, Shan J, Jin Y. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu Province: epidemiology, etiology, and disease burden. BMC Infect Dis. 2019;19(1):79–96. PMID: 30669973. doi:10.1186/s12879-018-3659-7.
   PubMed Web of Science ®Google Scholar
• Hawthorne G, Hawthorne G, Elliott P. Imputing cross-sectional missing data: comparison of common techniques. Aust N Z J Psychiatry. 2009;39(7):583–90. PMID: 15996139. doi:10.1080/j.1440-1614.2005.01630.x.
   Google Scholar
• Qiu J, Hu H, Zhou S, Liu Q. Vaccine scandal and crisis in public confidence in China. Lancet. 2016;387(10036):2382–2382. PMID: 27312311. doi:10.1016/S0140-6736(16)30737-1.
   PubMed Web of Science ®Google Scholar
• Murphy F. China vaccine scandal: investigations begin into faulty rabies and DTaP shots. BMJ. 2018;362:k3244. PMID: 30045923. doi:10.1136/bmj.k3244.
   PubMed Web of Science ®Google Scholar
• Chan YY, Cheng KY, Tam CH, Huang Z, Lee PY. Willingness of future A/H7N9 influenza vaccine uptake: a cross-sectional study of Hong Kong community. Vaccine. 2015;33(38):4737–40. PMID: 26226564. doi:10.1016/j.vaccine.2015.07.046.
   PubMed Web of Science ®Google Scholar
• Choi JS, Park S. A study on the predictors of Korean male students’ intention to receive human papillomavirus vaccination. J Clin Nurs. 2016;25(21–22):3354–62. PMID: 27378054. doi:10.1111/jocn.13461.
   PubMed Web of Science ®Google Scholar
• Lee JS, Mogasale V, Lim JK, Carabali M, Sirivichayakul C, Anh DD, Lee KS, Thiem VD, Limkittikul K, Tho le H, et al. A multi-country study of the household willingness-to-pay for dengue vaccines: household surveys in Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis. 2015;9(6):e0003810. PMID: 26378801. doi:10.1371/journal.pntd.0004070.
   PubMed Web of Science ®Google Scholar
• Harapan H, Anwar S, Bustamam A, Radiansyah A, Angraini P, Fasli R, Salwiyadi S, Bastian RA, Oktiviyari A, Akmal I, et al. Willingness to pay for a dengue vaccine and its associated determinants in Indonesia: a community-based, cross-sectional survey in Aceh. Acta Trop. 2017;166(Complete):249–256. PMID: 27908746. doi:10.1016/j.actatropica.2016.11.035.
   PubMedGoogle Scholar
• Dahlström LA, Tran TN, Lundholm C, Young C, Sundström K, Sparén P. Attitudes to HPV vaccination among parents of children aged 12–15 years – a population-based survey in Sweden. Int J Cancer. 2010;126(2):500–07. PMID: 19569173. doi:10.1002/ijc.24712.
   PubMed Web of Science ®Google Scholar
• Sjostrom O, Holst D Validity of a questionnaire survey: response patterns in different subgroups and the effect of social desirability. Acta Odontol Scand. 2002 Jun;60(3):136–40. PMID: 12166905. doi:10.1080/000163502753740133.
   PubMed Web of Science ®Google Scholar